The University of Southampton
University of Southampton Institutional Repository

Soluble adam33 augments the pulmonary immune response promoting allergic airway sensitivity

Soluble adam33 augments the pulmonary immune response promoting allergic airway sensitivity
Soluble adam33 augments the pulmonary immune response promoting allergic airway sensitivity
Rational: a disintegrin and metalloproteinase 33 (ADAM33) was discovered in 2002 as an asthma susceptibility gene. Genetic associations have been made between ADAM33 polymorphisms and asthma disease severity, bronchial hyperresponsivenss (BHR) and rate of lung function decline in both adults and children. A soluble, catalytically active form of the protein (sADAM33) has been identified in the bronchoalveolar lavage fluid of patients, levels of which correlate with disease severity (Lee JY et al, AJRCCM 2006). To study the role sADAM33, a lung specific, doxycycline (Dox) inducible, transgenic mouse, expressing the human pro and metalloproteinase domains of the full-length protein was generated (Ccsp-rtTA/Otet-ADAM33-Pro-MP). Induction of sADAM33, followed by house dust mite (HDM) sensitisation and challenge, resulted in increased BHR and airway inflammation (Davies ER et al, JCI-Insight 2016). The mechanisms by which ADAM33 promotes this susceptibility are unclear. The aim of this work is to identify pathways that are augmented by the induction of sADAM33, which promote increased sensitivity to allergen.

Methods: RNA samples from whole lung of adult mice, where sADAM33 had been induced for 4 or 8 weeks, were analysed by next generation RNA sequencing. Identified genes were confirmed across experimental time points (72 hour, 7 day, 4 and 8 weeks on Dox) in wider sample cohorts of Ccsp-rtTA/Otet-ADAM33-Pro-MP and control mice through RTqPCR.

Results: the predominant signal from the RNAseq output was for modulation of immune response genes at 4 weeks of sADAM33 expression (GO:0006955 Immune response: 31 genes, 58.49% coverage, FDR p value=7.09 E-22). Genes associated with an immune activation signature (Ccl5, Irgm1, Gm12250, Gzmb, Ncr1) were validated at least one time point. By 8 weeks of sADAM33 expression genes associated with negative regulation of the response were also validated (Ido1, Cd274).

Conclusion: induction of sADAM33 in murine lungs, without allergic sensitisation, augmented underlying immune processes in this transgenic mouse model, which may contribute to increased susceptibility to allergic airway inflammation and BHR when challenged with allergen. Further work is required to delineate how sADAM33 affects immune cell populations and their behaviour in the lung.
A55
BMJ
Kelly, Joanne, Freda Carmichael
5950d431-bc7e-4bad-817b-77446fc7332e
Davies, Elizabeth
aff6b3f7-91e0-4fd3-9554-a9389024b63b
Holgate, Stephen
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Xu, X
9cd134bc-210f-45ea-ae1e-0dd9b59c627f
Whitsett, J.A.
3fc6684d-66e9-43b3-98da-2c4c6236fcc3
Davies, Donna
7de8fdc7-3640-4e3a-aa91-d0e03f990c38
Haitchi, Hans
68dadb29-305d-4236-884f-e9c93f4d78fe
Kelly, Joanne, Freda Carmichael
5950d431-bc7e-4bad-817b-77446fc7332e
Davies, Elizabeth
aff6b3f7-91e0-4fd3-9554-a9389024b63b
Holgate, Stephen
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Xu, X
9cd134bc-210f-45ea-ae1e-0dd9b59c627f
Whitsett, J.A.
3fc6684d-66e9-43b3-98da-2c4c6236fcc3
Davies, Donna
7de8fdc7-3640-4e3a-aa91-d0e03f990c38
Haitchi, Hans
68dadb29-305d-4236-884f-e9c93f4d78fe

Kelly, Joanne, Freda Carmichael, Davies, Elizabeth, Holgate, Stephen, Xu, X, Whitsett, J.A., Davies, Donna and Haitchi, Hans (2017) Soluble adam33 augments the pulmonary immune response promoting allergic airway sensitivity. In Thorax. vol. 72, BMJ. A55 . (doi:10.1136/thoraxjnl-2017-210983.95).

Record type: Conference or Workshop Item (Paper)

Abstract

Rational: a disintegrin and metalloproteinase 33 (ADAM33) was discovered in 2002 as an asthma susceptibility gene. Genetic associations have been made between ADAM33 polymorphisms and asthma disease severity, bronchial hyperresponsivenss (BHR) and rate of lung function decline in both adults and children. A soluble, catalytically active form of the protein (sADAM33) has been identified in the bronchoalveolar lavage fluid of patients, levels of which correlate with disease severity (Lee JY et al, AJRCCM 2006). To study the role sADAM33, a lung specific, doxycycline (Dox) inducible, transgenic mouse, expressing the human pro and metalloproteinase domains of the full-length protein was generated (Ccsp-rtTA/Otet-ADAM33-Pro-MP). Induction of sADAM33, followed by house dust mite (HDM) sensitisation and challenge, resulted in increased BHR and airway inflammation (Davies ER et al, JCI-Insight 2016). The mechanisms by which ADAM33 promotes this susceptibility are unclear. The aim of this work is to identify pathways that are augmented by the induction of sADAM33, which promote increased sensitivity to allergen.

Methods: RNA samples from whole lung of adult mice, where sADAM33 had been induced for 4 or 8 weeks, were analysed by next generation RNA sequencing. Identified genes were confirmed across experimental time points (72 hour, 7 day, 4 and 8 weeks on Dox) in wider sample cohorts of Ccsp-rtTA/Otet-ADAM33-Pro-MP and control mice through RTqPCR.

Results: the predominant signal from the RNAseq output was for modulation of immune response genes at 4 weeks of sADAM33 expression (GO:0006955 Immune response: 31 genes, 58.49% coverage, FDR p value=7.09 E-22). Genes associated with an immune activation signature (Ccl5, Irgm1, Gm12250, Gzmb, Ncr1) were validated at least one time point. By 8 weeks of sADAM33 expression genes associated with negative regulation of the response were also validated (Ido1, Cd274).

Conclusion: induction of sADAM33 in murine lungs, without allergic sensitisation, augmented underlying immune processes in this transgenic mouse model, which may contribute to increased susceptibility to allergic airway inflammation and BHR when challenged with allergen. Further work is required to delineate how sADAM33 affects immune cell populations and their behaviour in the lung.

Full text not available from this repository.

More information

e-pub ahead of print date: 15 November 2017
Published date: 6 December 2017

Identifiers

Local EPrints ID: 418374
URI: https://eprints.soton.ac.uk/id/eprint/418374
PURE UUID: f5003136-09a3-4aad-a57c-7df15e7d1b0b
ORCID for Donna Davies: ORCID iD orcid.org/0000-0002-5117-2991
ORCID for Hans Haitchi: ORCID iD orcid.org/0000-0001-8603-302X

Catalogue record

Date deposited: 05 Mar 2018 17:30
Last modified: 24 May 2019 00:40

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×